Search
for
Sort by
Research 211–240 of 1000+
- Serum 1, 25-dihydroxy vitamin D- vitamin D3- among obese Egyptian women with polycystic ovary syndrome
- Serum C-19 steroid sulphates in females with clinical hyperandrogenism
- Clomiphene Citrate versus Letrozole for Ovulation Induction in PCOS: A Comparative Study
- Lack of association between clinical and biochemical hyperandrogenism in patients with polycystic ovary syndrome
- Intracrinology and Testosterone Pellet Therapy: An Enzyme-Aware, Symptom-Driven Approach to Hormone Optimization in Aging
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- Androgen effects on the skin
- Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane
- Oestrogen functions in skin and skin appendages
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women
- How to Evaluate Acne in Reproductive-Age Women: An Epidemiological Study in Chinese Communities
- Polyzystisches Ovar-Syndrom (PCOS)
- CONTRACEPTION AND THE SKIN
- Das polyzystische Ovarsyndrom: Aktuelle Evidenz und praktische Empfehlungen
- Hiperandrogenismo tras la menopausia
- New onset of alopecia in a young woman with end-stage renal disease
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Structure of human type II 5 alpha-reductase gene.
- Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor β Gene Are Associated with Androgen Levels in Women1
- Diagnosis of hyperandrogenism: Biochemical criteria
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Nonclassic adrenal hyperplasia
- Increased Androgen Binding Capacity in Sebaceous Glands in Scalp of Male-pattern Baldness
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Oxidative Activity of the Type 2 Isozyme of 17β-Hydroxysteroid Dehydrogenase (17β-HSD) Predominates in Human Sebaceous Glands